Beone Medicines revenue and financials

6160 · HKEX · HKD

Secondary listing. The primary listing is BeOne Medicines · NASDAQ (USD)

$217.00Change from previous close: −1.63%Absolute change: −$3.60

Close · October 7, 2026

In the fiscal year ended December 2025, Beone Medicines reported revenue of $5.34B (+40.23% year over year). Net income was $286.93M, a net margin of 5.4%.

Annual revenue · 2025: $5.34B
  1. $1.07M2016
  2. $238.39M2017
  3. $198.22M2018
  4. $428.21M2019
  5. $308.87M2020
  6. $1.18B2021
  7. $1.42B2022
  8. $2.46B2023
  9. $3.81B2024
  10. $5.34B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+40.23%
2025 vs 2024
Net margin
5.4%
2024: -16.9%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Annual
Item2025202420232022202120202019201820172016
Total assets8,1895,9215,8056,3798,6465,6011,6122,2501,046406
Current assets6,2343,9924,2035,2077,6144,9611,1731,944913374
Cash and equivalents4,5482,6273,1723,8704,3761,38261871324087.5
Short-term investments——2.66652,242—————
Receivables887709396199——————
Inventory608495416282——————
Net property, plant and equipment1,7161,6451,372924——————
Goodwill———0.10.10.10.10.10.1—
Other intangible assets14213010994.6——————
Long-term investments61.712989.691.8——————
Current liabilities1,8292,2151,8101,4691,6001,07531024615035.1
Accounts payable479405315295——————
Long-term debt8361,2151982091,28818458040.89.217.3
Total debt1,0931,080930597——————
Total liabilities3,8272,5892,2681,9962,4031,73263449636252.9
Total equity (incl. minority)4,3613,3323,5374,383——————
Retained earnings-8,320-8,607-7,962-7,080——————